Novartis returned to invest in Caribou Biosciences, which is developing genome engineering technology for therapeutics, agriculture and industrial biotechnology.

The Italy-based bank will own 40% of the fund, which has reached its first close, and which will invest in medtech, cleantech and advanced electronics.

The diet and fitness tracking app has added $6m from investors including IDG Ventures India to earlier funding from backers such as Micromax.

Northwestern University and Osage University Partners are among the investors in a series A round for the neurological disorder treatment developer, spun out of Northwestern spinout Naurex.

The biosimilar developer, backed by Strides Arcolab, floated at around half the price of its range having first filed for a $115m initial public offering in January 2016.

Gregory Verdine, a founder or co-founder of several publicly-listed pharmaceutical companies, has joined WuXi PharmaTech's investment arm as a venture partner.

The corporate-backed pharmaceutical company has postponed an initial public offering for the second time, a week after it set the terms.

Japanese pharmaceutical company Taiho Pharmaceutical has formed a corporate venturing subsidiary in California to invest in oncology startups.